stockrowRadNet, Inc. (RDNT) vs Veracyte, Inc. (VCYT)
- RadNet, Inc. RDNT 78.45 −2.26%
- Veracyte, Inc. VCYT 24.11 −54.09%
RadNet, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $6.1B against $1.9B — 3.2× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 17.5%. Veracyte, Inc. has the higher net margin (21.8% vs −0.93%) and the higher return on invested capital (4.33% vs 2.24%). Across the 20 metrics below, Veracyte, Inc. leads on 18 and RadNet, Inc. on 2.
Valuation
Profitability
| Metric | RDNT | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 11.53% | 71.98% | 48.32% |
| Operating margin | 3.12% | 17.08% | (5.68%) |
| Net margin | (0.93%) | 21.80% | (4.10%) |
| Free cash flow margin | 3.28% | 27.84% | 0.00% |
| Return on equity | (1.64%) | 9.43% | 0.00% |
| Return on assets | (0.55%) | 8.63% | (6.05%) |
| Return on invested capital | 2.24% | 4.33% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack